GSTM1 Protein (Glutathione S-Transferase Mu 1)

title: GSTM1 Protein (Glutathione S-Transferase Mu 1)

GSTM1 (Glutathione S-Transferase Mu 1) Protein

<div class="infobox infobox-protein">

| Property | Value |
|----------|-------|
| Protein Name | Glutathione S-transferase Mu 1 |
| Gene | GSTM1 |
| UniProt ID | P09488 |
| PDB ID | 1XWK, 3JUK, 4P3Q, 4LJQ |
| Molecular Weight | ~26 kDa |
| Subcellular Localization | Cytoplasm (predominant), mitochondria |
| Protein Family | Mu class glutathione S-transferase family |
| Expression | Ubiquitous, high in liver, brain |

</div>

Overview

Glutathione S-transferase Mu 1 (GSTM1) is a 218-amino acid cytosolic detoxification enzyme that catalyzes the conjugation of reduced glutathione (GSH) to a wide variety of electrophilic compounds. As a member of the Mu class of GSTs, GSTM1 plays a critical role in cellular detoxification of both endogenous reactive metabolites and exogenous xenobiotics, including environmental toxins, pesticides, and drugs[@hayes1995].

title: GSTM1 Protein (Glutathione S-Transferase Mu 1)

GSTM1 (Glutathione S-Transferase Mu 1) Protein

<div class="infobox infobox-protein">

| Property | Value |
|----------|-------|
| Protein Name | Glutathione S-transferase Mu 1 |
| Gene | GSTM1 |
| UniProt ID | P09488 |
| PDB ID | 1XWK, 3JUK, 4P3Q, 4LJQ |
| Molecular Weight | ~26 kDa |
| Subcellular Localization | Cytoplasm (predominant), mitochondria |
| Protein Family | Mu class glutathione S-transferase family |
| Expression | Ubiquitous, high in liver, brain |

</div>

Overview

Glutathione S-transferase Mu 1 (GSTM1) is a 218-amino acid cytosolic detoxification enzyme that catalyzes the conjugation of reduced glutathione (GSH) to a wide variety of electrophilic compounds. As a member of the Mu class of GSTs, GSTM1 plays a critical role in cellular detoxification of both endogenous reactive metabolites and exogenous xenobiotics, including environmental toxins, pesticides, and drugs[@hayes1995].

The GSTM1 gene is notable for its common null polymorphism (GSTM1*0), present in approximately 35-50% of populations of European and African descent, which results in complete loss of GSTM1 enzyme activity. This genetic variant has been extensively studied as a risk factor for [Parkinson's disease](/diseases/parkinsons-disease), [Alzheimer's disease](/diseases/alzheimers-disease), and [amyotrophic lateral sclerosis](/diseases/amyotrophic-lateral-sclerosis), where gene-environment interactions between GSTM1 deficiency and toxin exposure significantly increase disease risk[@kumar2021].

Structure

The GSTM1 protein exhibits the characteristic structure of cytosolic GSTs with specialized features for its detoxification function[@mannervik1985]:

Domain Architecture

• N-Terminal Domain (G-site, aa 1-80): Contains the glutathione (GSH) binding site that recognizes and binds the tripeptide GSH with high affinity. Key residues include Tyr6 and Gln67 that form hydrogen bonds with GSH.
• C-Terminal Domain (H-site, aa 90-218): The hydrophobic substrate binding site that accommodates a wide range of electrophilic substrates. This domain determines the substrate specificity of GSTM1.
• Active Site Cysteine (Cys47): The catalytic cysteine that forms a reversible bond with electrophilic substrates, facilitating the transfer to GSH.
• Conserved Mu Class Motifs: GSTM1 contains characteristic sequence motifs that define the Mu class:
• Mu-specific motif: Unique to class members
• Alpha-helical bundle: Characteristic GST fold
• Dimeric Structure: GSTM1 functions as a homodimer. Dimerization is required for enzymatic activity, as each monomer contributes to the formation of the active site at the dimer interface.

Substrate Specificity

GSTM1 has broad substrate specificity, conjugating:

| Category | Substrates |
|----------|-------------|
| Environmental | Pesticides, herbicides, industrial chemicals |
| Endogenous | Lipid peroxidation products (4-HNE, MDA) |
| Drugs | Certain chemotherapeutic agents |
| Neurotoxins | MPTP, 6-OHDA, paraquat metabolites |

Genetic Polymorphisms

| Variant | Effect | Frequency |
|---------|--------|-----------|
| GSTM1*0 (deletion) | Complete loss of activity | 35-50% Caucasian |
| GSTM1*2 | Normal activity | Common |
| GSTM1*3 | Variable | Rare |

The null genotype results from a 50 kb deletion spanning the entire GSTM1 gene.

Normal Function in the Nervous System

GSTM1 performs essential detoxification and neuroprotective functions in neurons and glia:

Detoxification

• Electrophile conjugation: Catalyzes conjugation of toxic electrophiles to GSH, making them water-soluble for excretion
• Xenobiotic metabolism: Processes exogenous compounds including pesticides, industrial chemicals, and drugs
• Endogenous metabolite clearance: Handles reactive endogenous compounds like lipid peroxidation products

Oxidative Stress Protection

• ROS detoxification: Reduces [reactive oxygen species](/entities/reactive-oxygen-species) (ROS) through GSH-dependent mechanisms
• Lipid peroxidation prevention: Conjugates 4-hydroxynonenal (4-HNE) and other lipid peroxidation products before they damage proteins and DNA
• DNA protection: Prevents oxidative DNA damage in [neurons](/entities/neurons)

Neuroprotection

• Environmental toxin defense: Guards against pesticide and industrial chemical neurotoxicity
• Inflammation modulation: Regulates inflammatory responses through modulation of electrophile signaling
• Mitochondrial protection: Protects mitochondrial proteins and membranes from oxidative damage

Cellular Signaling

• Electrophile signaling: Modulates electrophile-sensitive signaling pathways through conjugation
• MAPK regulation: GSTM1 can interact with MAP kinase pathways
• Apoptosis regulation: Modulates both pro- and anti-apoptotic responses

Role in Disease

Parkinson's Disease (PD)

GSTM1 deficiency is one of the most well-established genetic risk factors for PD[@standaert2018][@landi2000]:

Increased Oxidative Stress

• Reduced capacity to detoxify ROS and reactive electrophiles
• Accumulation of lipid peroxidation products in dopaminergic neurons
• Increased vulnerability to oxidative damage in the substantia nigra

• SNc dopaminergic neurons are particularly dependent on GSTM1
• High basal oxidative stress from dopamine metabolism
• GSTM1 deficiency exacerbates already high oxidative burden

The gene-environment interaction is critical:

• GSTM1 null + pesticide exposure = significantly higher PD risk
• GSTM1 null + MPTP exposure = increased toxicity
• Dose-response relationship with cumulative pesticide exposure

• Earlier onset: GSTM1 null associated with earlier PD onset (5-10 years earlier)
• Faster progression: More rapid disease progression in GSTM1 null individuals
• Severity: More severe motor symptoms in null genotype

Multiple studies have confirmed the association:

• Pooled odds ratio for PD: ~1.5-2.0 for GSTM1 null
• Significant in case-control and prospective studies
• Interaction with environmental exposures consistently observed

Alzheimer's Disease (AD)

GSTM1 involvement in AD:

Oxidative Damage

• Impaired defense against ROS in AD brain
• Accumulation of lipid peroxidation products (4-HNE)
• Correlation with disease severity

• Reduced clearance of [amyloid-beta](/proteins/amyloid-beta) (Aβ)-induced toxins
• GSTM1 expression is reduced in AD brain
• 4-HNE adducts accumulate in AD neurons

• Synergistic effect with [APOE](/proteins/apoe) ε4 allele
• APOE4 + GSTM1 null = highest AD risk
• Both involve lipid metabolism and oxidative stress

• GSTM1 null associated with increased AD risk
• Odds ratio approximately 1.3-1.5
• Interaction with environmental factors (smoking, pesticides)

Amyotrophic Lateral Sclerosis (ALS)

GSTM1 in motor neuron disease:

• GSTM1 null increases ALS risk
• Motor neurons are highly dependent on detoxification
• Gene-environment interactions with pesticides
• Association with faster progression

Multiple Sclerosis (MS)

• GSTM1 variants may affect demyelination risk
• Impaired detoxification in active lesions
• Oxidative stress in demyelinating disease

Therapeutic Targeting

Approaches for GSTM1 Deficiency

| Approach | Status | Notes |
|----------|--------|-------|
| Glutathione supplementation | Phase 2 | Bypass GSTM1 deficiency |
| NAC (N-acetylcysteine) | Phase 1-2 | GSH precursor |
| Sulforaphane | Phase 1 | Nrf2 activator |
| Gene therapy | Preclinical | Not practical |

Experimental Strategies

Bypass Strategies

• Glutathione administration: Direct GSH supplementation
• N-acetylcysteine (NAC): Provides cysteine for GSH synthesis
• GSH analogs: Stable GSH mimetics

• Nrf2 activators: Sulforaphane, oltipraz increase GSTM1 transcription
• Transcriptional regulators: Enhance endogenous expression

• Antioxidants: Reduce generation of electrophiles
• Toxin avoidance: Reduce exposure to GSTM1 substrates

Mechanism of Action

Catalytic Cycle

Detoxification Pathways

Interaction with Nrf2

GSTM1 is regulated by Nrf2-ARE signaling:

• Nrf2 activation transcriptionally induces GSTM1
• GSTM1 is one of the premier Nrf2 target genes
• Nrf2-GSTM1 axis provides defense against electrophiles
• This pathway is impaired in neurodegenerative disease

Key Publications

Cross-links

• [GSTM1 Gene](/genes/gstm1) — Gene page for GSTM1
• [Parkinson's Disease](/diseases/parkinsons-disease) — Disease page with GSTM1 involvement
• [Alzheimer's Disease](/diseases/alzheimers-disease) — Disease page with GSTM1 involvement
• [Oxidative Stress Pathway](/mechanisms/oxidative-stress) — Core mechanism
• [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis) — Disease page with GSTM1 involvement
• [Glutathione Pathway](/mechanisms/glutathione-metabolism) — Related pathway

External Links

• [Human Protein Atlas: GSTM1](https://www.proteinatlas.org/ENSG00000166759-GSTM1)
• [UniProt: GSTM1](https://www.uniprot.org/uniprotkb/P09488)
• [PDGene: GSTM1](https://www.pdgene.org/gene.4112)
• [AlzGene: GSTM1](https://www.alzgene.org/gene/GSTM1)

See Also

• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Oxidative Stress Pathway](/mechanisms/oxidative-stress)
• [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)
• [Glutathione Pathway](/mechanisms/glutathione-metabolism)

References

Pathway Diagram

The following diagram shows the key molecular relationships involving GSTM1 Protein (Glutathione S-Transferase Mu 1) discovered through SciDEX knowledge graph analysis: